IMRX
Immuneering Corp
4.30$
-0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.5% | +42.0% | -2.6% | +12.5% | -11.8% | -27.0% | -60.7% | -3.1% | -48.6% | -59.4% | -98.8% | -100.0% | – | -100.0% | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -7.0% | +32.9% | +50.2% | -13.5% | -22.1% | -31.2% | -5.9% | -55.9% | +175.5% | -92.3% | +816,546.2% | -99.9% | +2.0% | +1.2% | -5.4% | +1.3% | -6.5% | +0.1% | -0.6% | +0.6% | -47.7% | -6.2% | +611.2% | -70.5% | +0.0% | – | |
| – | +6.9% | +50.8% | -47.8% | +76.7% | +0.7% | -23.0% | -106.3% | – | -267.9% | – | -97.6% | -41,776.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +14.1% | +26.3% | +20.2% | +10.2% | +29.7% | -11.2% | +28.1% | +13.9% | -12.3% | +17.9% | +5.4% | +3.4% | -8.0% | +7.0% | +17.9% | -5.5% | -4.9% | +5.6% | +31.5% | -22.5% | -8.9% | +4.0% | -14.3% | +114,185.0% | -99.9% | – | |
| – | -2.3% | +11.0% | +62.8% | +4.1% | +13.2% | +94.0% | +21.1% | +25.5% | -6.3% | +3.6% | +7.1% | +6.7% | -7.7% | -4.4% | +13.3% | -6.1% | +3.4% | -5.6% | -8.0% | +8.4% | +7.2% | +4.9% | +0.1% | +103,732.2% | -99.9% | – | |
| – | +11.1% | +23.8% | +26.4% | +9.1% | +26.7% | +5.7% | +26.0% | +17.3% | -11.7% | +14.9% | +5.9% | +5.0% | -9.3% | +4.6% | +15.7% | -4.9% | -2.7% | +2.4% | +20.4% | -15.8% | -4.7% | +4.2% | -14.6% | +15.3% | +25.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -93.6% | -53.4% | -55.0% | +1,126.8% | -48.7% | +433.9% | +20,385.3% | -96.3% | +7.8% | +56.2% | +131.5% | +208,243.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -159.6% | – | – | – | -2,293.5% | – | – | – | – | – | – | – | – | – | – | – | – | -21.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.